尽管目前全球仅有5000名婴幼儿使用该药，但罕见病药物的高定价模式，叠加长期持续给药的治疗需求，让Vosoritide的商业表现持续走高。2025年，该药销售额达9.27亿美元，同比增长26%，是BioMarin的核心商业化增长引擎。
TechCrunch Daily News
。业内人士推荐新收录的资料作为进阶阅读
Hurdle Word 1 hintPathway.
4.7 901. 股票价格跨度
The proposals are being made through an amendment to the Crime and Policing Bill, which is making its way through the House of Lords.